HRT Financial’s Accelevation Holdings Corp. Class A Ordinary Shares ACCV Stock Holding History

HRT Financial’s Portfolio ACCV Stock Details ACCV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.43M	Buy	+525,371	New	+$9.43M	0.02%	885

Other funds holding ACCV

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Tortoise Capital Advisors Overland Park, Kansas $9.47B AUM 23.61% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $33B AUM 30.04% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return

HRT Financial's ACCV Position: Q3 2026 in Review

HRT Financial opened a new position in Accelevation Holdings Corp. Class A Ordinary Shares (ACCV) in Q3 2026: 525,371 shares worth $9.43M. The stake represents 0.02% of the portfolio and ranks #885 among its holdings.

30 funds tracked by Wall St. Rank hold ACCV as of Q3 2026.

HRT Financial held 525,371 shares of Accelevation Holdings Corp. Class A Ordinary Shares worth $9.43M as of Q3 2026.
Accelevation Holdings Corp. Class A Ordinary Shares was a new HRT Financial position in Q3 2026.
Accelevation Holdings Corp. Class A Ordinary Shares made up 0.02% of HRT Financial's portfolio in Q3 2026, its #885 holding.
30 funds tracked by Wall St. Rank held Accelevation Holdings Corp. Class A Ordinary Shares as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.